Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

CYP2J27 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients.

Ahmed JH, Makonnen E, Yimer G, Seifu D, Bekele A, Assefa M, Aseffa A, Howe R, Fotoohi A, Hassan M, Aklillu E.

Front Pharmacol. 2019 May 14;10:481. doi: 10.3389/fphar.2019.00481. eCollection 2019.

2.

Vitamin D Status and Association of VDR Genetic Polymorphism to Risk of Breast Cancer in Ethiopia.

Ahmed JH, Makonnen E, Fotoohi A, Yimer G, Seifu D, Assefa M, Tigeneh W, Aseffa A, Howe R, Aklillu E.

Nutrients. 2019 Jan 29;11(2). pii: E289. doi: 10.3390/nu11020289.

3.

Improved glucose metabolism by Eragrostis tef potentially through beige adipocyte formation and attenuating adipose tissue inflammation.

Lemecha M, Morino K, Seifu D, Imamura T, Nakagawa F, Nagata A, Okamato T, Sekine O, Ugi S, Maegawa H.

PLoS One. 2018 Aug 2;13(8):e0201661. doi: 10.1371/journal.pone.0201661. eCollection 2018.

4.
5.

Clinical bacteriology in low-resource settings: today's solutions.

Ombelet S, Ronat JB, Walsh T, Yansouni CP, Cox J, Vlieghe E, Martiny D, Semret M, Vandenberg O, Jacobs J; Bacteriology in Low Resource Settings working group.

Lancet Infect Dis. 2018 Aug;18(8):e248-e258. doi: 10.1016/S1473-3099(18)30093-8. Epub 2018 Mar 5. Review.

PMID:
29519767
6.

Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa.

Hadgu E, Seifu D, Tigneh W, Bokretsion Y, Bekele A, Abebe M, Sollie T, Merajver SD, Karlsson C, Karlsson MG.

BMC Womens Health. 2018 Feb 14;18(1):40. doi: 10.1186/s12905-018-0531-2.

7.

Antidiabetic and gastric emptying inhibitory effect of herbal Melia azedarach leaf extract in rodent models of diabetes type 2 mellitus.

Seifu D, Gustafsson LE, Chawla R, Genet S, Debella A, Holst M, Hellström PM.

J Exp Pharmacol. 2017 Mar 20;9:23-29. doi: 10.2147/JEP.S126146. eCollection 2017.

8.

Lipid Peroxidation and Altered Antioxidant Profiles with Pediatric HIV Infection and Antiretroviral Therapy in Addis Ababa, Ethiopia.

Mebrat Y, Amogne W, Mekasha A, Gleason RL Jr, Seifu D.

J Trop Pediatr. 2017 Jun 1;63(3):196-202. doi: 10.1093/tropej/fmw076.

PMID:
27940963
9.

Establishment of reference intervals of thyroid function tests from cord blood of neonates in two selected hospitals, Addis Ababa, Ethiopia.

Mehari A, Challa F, Gebreyesus G, Alemayehu D, Seifu D.

BMC Pediatr. 2016 Aug 2;16:118. doi: 10.1186/s12887-016-0654-2.

10.

Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in Ethiopia.

Gleason RL Jr, Caulk AW, Seifu D, Rosebush JC, Shapiro AM, Schwartz MH, Eckard AR, Amogne W, Abebe W.

J Biomech. 2016 Sep 6;49(13):2584-2592. doi: 10.1016/j.jbiomech.2016.05.018. Epub 2016 May 21.

PMID:
27270208
11.

Low-Cost Method to Monitor Patient Adherence to HIV Antiretroviral Therapy Using Multiplex Cathepsin Zymography.

Platt MO, Evans D, Keegan PM, McNamara L, Parker IK, Roberts LM, Caulk AW, Gleason RL Jr, Seifu D, Amogne W, Penny C.

Mol Biotechnol. 2016 Jan;58(1):56-64. doi: 10.1007/s12033-015-9903-0.

12.

Current Efavirenz (EFV) or ritonavir-boosted lopinavir (LPV/r) use correlates with elevate markers of atherosclerosis in HIV-infected subjects in Addis Ababa, Ethiopia.

Gleason RL Jr, Caulk AW, Seifu D, Parker I, Vidakovic B, Getenet H, Assefa G, Amogne W.

PLoS One. 2015 Apr 27;10(4):e0117125. doi: 10.1371/journal.pone.0117125. eCollection 2015.

Supplemental Content

Loading ...
Support Center